Antibody Array for Protein Conformational Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for analyzing the three-dimensional structure of proteins, particularly for protein therapeutics, are limited by low sensitivity, slow analysis times, and low throughput, making it difficult to accurately and efficiently determine the conformational stability and immunogenicity of biologics.
Innovation Solution
An antibody array system that specifically binds to epitopes on the surface of proteins, allowing for sensitive and systematic measurement of their three-dimensional structure, enabling comparison of protein conformational structures by quantifying antibody-protein complexes, and providing a kit for assessing the conformational comparability of therapeutic proteins and biosimilars.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional methods (Molecular Sieve, Ultracentrifugation, fluorescence, CD spectrum, gel electrophoresis) are used to analyze protein 3-D structure, then the analysis can be performed with existing equipment, but the sensitivity is low and cannot distinguish regional differences
Solution Approach 1:
The patent divides the protein analysis into multiple epitope regions by using a panel of conformation-specific antibodies, each targeting specific epitopes. This segmentation allows regional differentiation of protein conformation changes that conventional methods cannot detect, thereby improving measurement precision without requiring fundamentally new equipment.
Solution Approach 2:
The patent transitions from conventional bulk measurement approaches to a multi-dimensional epitope-specific measurement system. By analyzing multiple epitope regions simultaneously through antibody arrays or ELISA panels, the method adds dimensional resolution to conformation analysis, enabling detection of localized structural changes while maintaining compatibility with existing immunological assay platforms.
2Loss of time
If conventional protein conformation analysis methods are used, then the equipment is readily available, but the analysis time is slow (more than 24 hours)
Solution Approach 1:
The patent employs pre-prepared conformation-specific antibodies that have been specifically raised against native conformational epitopes. These antibodies are ready for immediate use in high-throughput screening, eliminating the need for time-consuming method development and optimization for each new protein, thus reducing analysis time while maintaining detailed conformational measurement capability.
Solution Approach 2:
The patent changes the measurement parameters from bulk physical/chemical properties to epitope-specific binding responses. By using multiple conformation-specific antibodies in parallel assays, the method achieves detailed conformational analysis in a fraction of the time required by conventional sequential methods, as all epitope measurements can be performed simultaneously rather than sequentially over 24+ hours.
3Productivity
If conventional methods are used for protein analysis, then the procedure is simple, but the throughput is low (only one or a few samples at a time)
Solution Approach 1:
The patent merges multiple epitope-specific antibody assays into integrated arrays or panel systems. By combining several conformation-specific antibodies targeting different epitopes into a single array format or multiplexed ELISA panel, the method achieves high throughput analysis of multiple samples while maintaining detailed conformational resolution through the combined epitope coverage of all antibodies in the array.
Solution Approach 2:
The patent creates universal conformation-specific antibody panels that can be applied to analyze different protein therapeutics and biosimilars. These multi-functional antibody arrays provide both high throughput capability for screening multiple samples and detailed conformational resolution through their ability to detect epitope-specific changes across different protein targets, eliminating the need for separate method development for each sample type.
4Productivity
If an antibody array system is implemented for detailed epitope-specific analysis, then sensitivity and throughput improve, but the device and procedure complexity increases
Solution Approach 1:
The patent uses standardized array formats and automated detection systems that replicate successful existing technologies. By adapting proven microarray and ELISA platform designs for conformation-specific antibody applications, the system achieves high throughput and sensitivity while minimizing the learning curve and operational complexity, as the underlying technology platforms are well-established and familiar to laboratory personnel.
Solution Approach 2:
The patent replaces complex manual analysis procedures with automated detection and data processing systems. By using automated plate readers, fluorescence detectors, and software-based data analysis pipelines, the system achieves high throughput and detailed conformational resolution while reducing the manual operational complexity. The automation handles the complexity of multi-epitope, multi-sample analysis, leaving users with simplified sample preparation and result interpretation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The antibody array system provides a rapid, sensitive, and systematic method for analyzing protein conformation, facilitating the detection of subtle changes in protein structure and heterogeneity, which is crucial for ensuring the stability and efficacy of biologics and biosimilars, thereby streamlining the development and approval process.
Implementation Method 1
an antibody array that specifically bind to epitopes that cover the surface of a protein
Data Source
AI summary
This disclosure provides an antibody array for the analysis of the three-dimensional structure of a protein. It includes the development and production of the antibody array and methods of using the array to analyze the three-dimensional structure of a protein as well as to compare the three-dimensional structure of two proteins, for example, a therapeutic protein and a biosimilar, to determine if the two proteins are similar.